Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Español Near me My list Help
US Patient GuideUSA
Surprise me
Brand-name prescription medicine

Cystografin Dilute

Generic name: Diatrizoate meglumine

FDA application holder: Bracco

Strengths and generic versions Official label

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

At a glance

1Strengths and forms
0Same medicine, other names
1955FDA approval
0Recalls (FDA reports)

Quick answers

What is Cystografin Dilute?
Cystografin Dilute is a brand name of Diatrizoate meglumine, a prescription medicine. The FDA NDC Directory lists 1 Cystografin Dilute product in 1 strength and form.
Who makes Cystografin Dilute?
Bracco holds the FDA application for Cystografin Dilute (NDA010040, approved August 2, 1955).
Is there a generic or store brand of Cystografin Dilute?
Other products of Diatrizoate meglumine are listed with the FDA, but none in exactly the same strength and form as a Cystografin Dilute product.
Has Cystografin Dilute been recalled?
No recall linked to Cystografin Dilute products (by their NDC code or label) appears in the FDA enforcement reports we use.

What Cystografin Dilute is

Each Cystografin Dilute product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Diatrizoate meglumine · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
diatrizoate meglumine 180 mg/mL
injection, solution (intravesical)		 Cystografin Dilute None listed DailyMed

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Diatrizoate meglumine →

FDA approval

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
FDA applications of Cystografin Dilute products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
NDA010040BraccoAugust 2, 19551

Companies that list Cystografin Dilute

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Cystografin Dilute products.

Recalls

No recall linked to Cystografin Dilute products (by their NDC code or label) appears in the FDA enforcement reports.

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers